Insulin Delivery in Type 2 Diabetes: To Pump or Not to Pump?

July 10, 2015

The American Diabetes Association and European Association for the Study of Diabetes (ADA/EASD) guidelines acknowledge that “CSII is a less commonly used and more costly alternative” to basal-bolus therapy in patients with T2DM.  The Opt2mise was a robust study intended to clarify the role of CSII in patients with T2DM.

00:0000:00

Facebook Comments: